C4 Therapeutics, Inc. (CCCC)
NASDAQ: CCCC · Real-Time Price · USD
4.260
-0.140 (-3.18%)
At close: Jun 26, 2026, 4:00 PM EDT
4.401
+0.141 (3.31%)
After-hours: Jun 26, 2026, 7:52 PM EDT
C4 Therapeutics Employees
C4 Therapeutics had 104 employees as of December 31, 2025. The number of employees decreased by 6 or -5.45% compared to the previous year.
Employees
104
Change (1Y)
-6
Growth (1Y)
-5.45%
Revenue / Employee
$335,202
Profits / Employee
-$998,087
Market Cap
471.02M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cabaletta Bio | 158 |
| Neurogene | 131 |
| Ocugen | 116 |
| Artiva Biotherapeutics | 106 |
| Prothena Corporation | 67 |
| Contineum Therapeutics | 51 |
| Shattuck Labs | 40 |
CCCC News
- 3 days ago - C4 Therapeutics Transcript: AGM 2026 - Transcripts
- 9 days ago - C4 Therapeutics Transcript: KOL event - Transcripts
- 9 days ago - C4 Therapeutics Slides: KOL event - Filings
- 16 days ago - C4 Therapeutics presents further analysis from cemsidomide trial - TheFly
- 16 days ago - C4 Therapeutics Presents Phase 1 Data at European Hematology Association (EHA) 2026 Congress Highlighting Cemsidomide as a Potential Best-in-Class IKZF1/3 Degrader for Multiple Myeloma in Heavily Pretreated Relapsed/Refractory Population - GlobeNewsWire
- 16 days ago - C4 Therapeutics Slides: Corporate presentation - Filings
- 23 days ago - C4 Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - C4 Therapeutics jumps after Bristol Myers myeloma data - TheFly